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dramatically improved the health of a large number of
the world’s population. Consequently, life expectancy
has substantially increased, and with it, health issues re-
lated to aging. According to the United Nations Depart-
ment of Economic and Social Affairs, 10% of the world’s
population was 60 years or older in 2000. This group will
increase to 20% of the population by 2050, and by 2150,
one out of three persons will be 60 years or older. The
physical well-being of this growing pool of aging individ-
uals is a major concern for most governments because
of the potential strain on the health-care system, and be-
cause these individuals remain a valuable—and are be-
coming an increasingly sizeable—economic force. Evi-
dently, there is a need to better understand the biology
of aging to both prevent and treat age-related diseases.
‘‘Immunosenescence’’ describes the changes in the
immune system when an organism ages. The efficiency
of the immune system deteriorates with time, resulting
in increased susceptibility of the elderly to illnesses
such as infectious diseases, cancers, and autoimmune
diseases. Immunologists are starting to gain a better
appreciation of how aging affects immunity and, in turn,
of how the changes in the immune system affect the ag-
ing process. In this and the next issue of Immunity, we
have invited four experts in the field to comment on
the current understanding of aging and the immune sys-
tem, and to shed light on the outstanding areas of re-
search that necessitate further attention.
Solana and colleagues lead off the discussion in this
issue by examining aging and the innate arm of the im-
mune system. Various studies have suggested aging
has profound effects on the number and functions of
neutrophils, macrophages, dendritic cells, and natural
killer cells. Aging appears to affect the different cell
types in specific ways, such as decreasing the phago-
cytic capacity of macrophages but not of neutrophils,
and impairing the antigen presentation of macrophages
but not that of dendritic cells. Importantly, there ap-
pears to be a marked difference in the competence of
the immune cells between healthy and frail individuals.
Clearly, many questions remain in understanding how
aging affects the innate immune system at the molecu-
lar and mechanistic level, such as the expression of key
receptors and the signaling pathways of these recep-
tors, as well as at the cellular level, such as the changes
in cell numbers and the types of cells affected. It is also
apparent that further studies must consider the health
status of the aging individual.
The adaptive immune system receives cues from the
innate arm of the immune system to mount an efficientand potent response. Weng follows Solana and col-
leagues’ discussion by focusing on the changes in T
and B cells with age. Naive CD4+ T cells appear to lose
their proliferative capacity and cytokine secretion ca-
pacity as a function of the age of the cells rather than
the age of the individual. This understanding cautions
against any strategy that would prolong the lifespan of
naive CD4+ T cells, but it also provides a rationale for
effective immune interventions that target the de novo
generation of naive CD4+ T cells. Weng further high-
lights the observation that decreased output of new
CD8+ T cells and B cells during aging leads to memory
cells filling the available ‘‘space,’’ which, in turn, results
in an oligoclonal repertoire of lymphocytes. The re-
stricted spectrum of lymphocytes might be less capable
of responding to newly encountered antigens. Among
the various efforts to elucidate the mechanistic under-
pinnings of the increasingly incompetent lymphocytes
in the elderly is the interesting quest to gain a better un-
derstanding of the control of telomere length in these
cells. Because telomere length regulates cell division
and hence longevity, the ability to manipulate telomere
length may also directly affect the competency of these
immune cells.
In the next issue of Immunity, Montecino-Rodriguez
and Dorshkind will continue the discussion on lympho-
cytes by examining the critical question of how aging af-
fects the generation of these cells. ‘‘Thymic involution’’
is commonly associated with the aging immune system,
but the output of B cells is also markedly affected in old-
er individuals. Although it is clear that lymphocyte out-
put diminishes with time, the most important question
yet to be adequately addressed is what are the precise
intrinsic and extrinsic factors that control lymphopoie-
sis during aging? Haynes and Swain will also discuss
many of the factors that affect lymphocyte functions
and conclude this series of commentaries by relating
the lymphocyte defects to specific vaccination strate-
gies for the elderly.
With increasing life expectancy, quality of life for the
elderly will depend largely on the ability to maintain
a healthy body. An inefficient or aberrant immune sys-
tem enhances the susceptibility of an individual to vari-
ous diseases. Although many of these diseases, such as
infections, autoimmune diseases, and cancers, are not
confined to the elderly, management of these diseases
in the elderly requires a thorough understanding of the
fundamental changes in the immune system with age.
This knowledge will form the foundation of effective pre-
vention and therapeutic programs for a healthier aging
population.
